CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
OncoImmunity is developing a machine learning framework to enhance the identification of neoantigens for personalized cancer vaccines. This technology aims to improve the accuracy and efficiency of cancer treatment by using patient-specific data to create tailored immunotherapies.
Cancer is arguably the most feared of all diseases, destroying lives regardless of the age of its victims.
Immunotherapies are currently regarded as the most promising avenue to delivering the holy grail of medicine i.e. providing a cure for cancer.
Despite their Nobel-winning status, personalisation of immunotherapies remains akey challenge to which no cost-effective solution currently exists.
Current methods for identifying the immunogenic neoantigens required to design patient-specific cancer…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
